发明申请
US20050069878A1 Proteins associated with cell growth, differentiation, and death
审中-公开
与细胞生长，分化和死亡相关的蛋白质
- 专利标题： Proteins associated with cell growth, differentiation, and death
- 专利标题（中）： 与细胞生长，分化和死亡相关的蛋白质
-
申请号： US10481041申请日： 2002-06-12
-
公开(公告)号： US20050069878A1公开(公告)日： 2005-03-31
- 发明人: Henry Yue , Dyung Lu , April Hafalia , Chandra Arvizu , Jayalaxmi Ramkumar , Y Tang , Farrah Khan , Barrie Greene , Thomas Richardson , Junming Yang , Craig Ison , Bridget Warren , Vicki Elliott , Brooke Emerling , Ann Gorvard , Ernestine Lee , Jennifer Griffin , Yeganeh Zebarjadian , Anita Swarnakar , Preeti Lal , Mariah Baughn , Uyen Tran , Sally Lee , Ian Forsythe , Janice Au-Young
- 申请人： Henry Yue , Dyung Lu , April Hafalia , Chandra Arvizu , Jayalaxmi Ramkumar , Y Tang , Farrah Khan , Barrie Greene , Thomas Richardson , Junming Yang , Craig Ison , Bridget Warren , Vicki Elliott , Brooke Emerling , Ann Gorvard , Ernestine Lee , Jennifer Griffin , Yeganeh Zebarjadian , Anita Swarnakar , Preeti Lal , Mariah Baughn , Uyen Tran , Sally Lee , Ian Forsythe , Janice Au-Young
- 国际申请： PCT/US02/18834 WO 20020612
- 主分类号： G01N33/50
- IPC分类号： G01N33/50 ; A01K67/00 ; A61K38/00 ; A61K39/395 ; A61K45/00 ; A61K48/00 ; A61P1/16 ; A61P3/10 ; A61P7/06 ; A61P9/10 ; A61P11/00 ; A61P11/06 ; A61P15/00 ; A61P15/10 ; A61P17/06 ; A61P19/00 ; A61P19/02 ; A61P19/06 ; A61P21/00 ; A61P25/00 ; A61P25/08 ; A61P25/16 ; A61P25/20 ; A61P25/28 ; A61P27/06 ; A61P27/12 ; A61P29/00 ; A61P31/04 ; A61P31/12 ; A61P31/18 ; A61P33/00 ; A61P35/00 ; A61P35/02 ; A61P37/00 ; A61P37/08 ; C07H21/04 ; C07K1/14 ; C07K14/47 ; C07K14/475 ; C07K16/18 ; C07K16/46 ; C12M1/00 ; C12N1/15 ; C12N1/19 ; C12N1/21 ; C12N5/10 ; C12N9/64 ; C12N15/09 ; C12P21/02 ; C12P21/08 ; C12Q1/68 ; G01N33/15 ; G01N33/53
摘要：
Various embodiments of the invention provide human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.
信息查询
IPC分类:
